Cardioprotection in cardiovascular surgery
- PMID: 38856733
- DOI: 10.1007/s00395-024-01062-0
Cardioprotection in cardiovascular surgery
Abstract
Since the invention of cardiopulmonary bypass, cardioprotective strategies have been investigated to mitigate ischemic injury to the heart during aortic cross-clamping and reperfusion injury with cross-clamp release. With advances in cardiac surgical and percutaneous techniques and post-operative management strategies including mechanical circulatory support, cardiac surgeons are able to operate on more complex patients. Therefore, there is a growing need for improved cardioprotective strategies to optimize outcomes in these patients. This review provides an overview of the basic principles of cardioprotection in the setting of cardiac surgery, including mechanisms of cardiac injury in the context of cardiopulmonary bypass, followed by a discussion of the specific approaches to optimizing cardioprotection in cardiac surgery, including refinements in cardiopulmonary bypass and cardioplegia, ischemic conditioning, use of specific anesthetic and pharmaceutical agents, and novel mechanical circulatory support technologies. Finally, translational strategies that investigate cardioprotection in the setting of cardiac surgery will be reviewed, with a focus on promising research in the areas of cell-based and gene therapy. Advances in this area will help cardiologists and cardiac surgeons mitigate myocardial ischemic injury, improve functional post-operative recovery, and optimize clinical outcomes in patients undergoing cardiac surgery.
Keywords: Cardioprotection; Cardiopulmonary bypass; Cardiovascular surgery.
© 2024. Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Aass T, Stangeland L, Chambers DJ, Hallström S, Rossmann C, Podesser BK, Urban M, Nesheim K, Haaverstad R, Matre K, Grong K (2017) Myocardial energy metabolism and ultrastructure with polarizing and depolarizing cardioplegia in a porcine model. Eur J Cardiothorac Surg 52:180–188. https://doi.org/10.1093/ejcts/ezx035 - DOI - PubMed - PMC
-
- Abdelshafy M, Caliskan K, Guven G, Elkoumy A, Elsherbini H, Elzomor H, Tenekecioglu E, Akin S, Soliman O (2022) Temporary right-ventricular assist devices: a systematic review. J Clin Med 11:613. https://doi.org/10.3390/jcm11030613 - DOI - PubMed - PMC
-
- Abel F, Murke F, Gaida M, Garnier N, Ochsenfarth C, Theiss C, Thielmann M, Kleinbongard P, Giebel B, Peters J, Frey UH (2020) Extracellular vesicles isolated from patients undergoing remote ischemic preconditioning decrease hypoxia-evoked apoptosis of cardiomyoblasts after isoflurane but not propofol exposure. PLoS ONE 15:e0228948. https://doi.org/10.1371/journal.pone.0228948 - DOI - PubMed - PMC
-
- Ahmed HM, Khraishah H, Cho L (2018) Cardioprotective anti-hyperglycaemic medications: a review of clinical trials. Eur Heart J 39:2368–2375. https://doi.org/10.1093/eurheartj/ehx668 - DOI - PubMed
-
- Allen BS, Winkelmann JW, Hanafy H, Hartz RS, Bolling KS, Ham J, Feinstein S (1995) Retrograde cardioplegia does not adequately perfuse the right ventricle. J Thorac Cardiovasc Surg 109:1116–1124. https://doi.org/10.1016/S0022-5223(95)70195-8 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
